Loading...

elexxion AG

E8X.DEXETRA
Healthcare
Medical - Devices
0.14
0.002(1.45%)
German Market opens in 14h 31m

elexxion AG Fundamental Analysis

elexxion AG (E8X.DE) shows moderate financial fundamentals with a PE ratio of -1.41, profit margin of -2.21%, and ROE of 28.67%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE28.67%
PEG Ratio-0.01
Current Ratio1.79

Areas of Concern

Operating Margin-1.95%
Cash Position4.45%
We analyze E8X.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -133.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-133.4/100

We analyze E8X.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

E8X.DE struggles to generate sufficient returns from assets.

ROA > 10%
-21.53%

Valuation Score

Excellent

E8X.DE trades at attractive valuation levels.

PE < 25
-1.41
PEG Ratio < 2
-0.01

Growth Score

Weak

E8X.DE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

E8X.DE maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.04
Current Ratio > 1
1.79

Profitability Score

Weak

E8X.DE struggles to sustain strong margins.

ROE > 15%
28.67%
Net Margin ≥ 15%
-2.21%
Positive Free Cash Flow
No

Key Financial Metrics

Is E8X.DE Expensive or Cheap?

P/E Ratio

E8X.DE trades at -1.41 times earnings. This suggests potential undervaluation.

-1.41

PEG Ratio

When adjusting for growth, E8X.DE's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values elexxion AG at -0.35 times its book value. This may indicate undervaluation.

-0.35

EV/EBITDA

Enterprise value stands at 2.96 times EBITDA. This is generally considered low.

2.96

How Well Does E8X.DE Make Money?

Net Profit Margin

For every $100 in sales, elexxion AG keeps $-2.21 as profit after all expenses.

-2.21%

Operating Margin

Core operations generate -1.95 in profit for every $100 in revenue, before interest and taxes.

-1.95%

ROE

Management delivers $28.67 in profit for every $100 of shareholder equity.

28.67%

ROA

elexxion AG generates $-21.53 in profit for every $100 in assets, demonstrating efficient asset deployment.

-21.53%

Following the Money - Real Cash Generation

Operating Cash Flow

elexxion AG generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

elexxion AG generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

E8X.DE converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.41

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.30

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.79

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.29

vs 25 benchmark

ROA

Return on assets percentage

-0.22

vs 25 benchmark

ROCE

Return on capital employed

-0.21

vs 25 benchmark

How E8X.DE Stacks Against Its Sector Peers

MetricE8X.DE ValueSector AveragePerformance
P/E Ratio-1.4129.88 Better (Cheaper)
ROE28.67%682.00% Weak
Net Margin-221.47%-46037.00% (disorted) Weak
Debt/Equity-1.040.42 Strong (Low Leverage)
Current Ratio1.794.49 Neutral
ROA-21.53%-16420.00% (disorted) Weak

E8X.DE outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews elexxion AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ